Journal of Medicinal Chemistry p. 1404 - 1408 (1981)
Update date:2022-08-05
Topics:
Brandt, Joan A.
Ludeman, Susan Marie
Zon, Gerald
Todhunter, John A.
Egan, William
Dickerson, Ruth
Hydrogenolysis of 3-(benzyloxy)cyclophosphamide (10) using Pd/C catalyst and ethyl acetate as solvent leads to the formation of 3-hydroxycyclophosphamide (3, ca. 20percent) and cyclophosphamide (1, ca. 10percent), accompanied by regioselective hydrogen-exchange reactions at the C-4 and C-5 positions in 3 and 1.A variety of oxidizing reagents and liver microsomal incubation failed to provide evidence (31P NMR) for conversion of 1 into 3, whereas identical incubation of 3 led to its reduction to 1.Compound 3 is stable at pH 6.5-8.2, 37 deg C, and exhibits anticancer activity comparable to 1 when tested against L1210 leukemia in mice.Data are discussed with regard to a previously reported suggestion that metabolism of 1 may involve oxidation to give 3 followed by rearrangement of 3 to 2.
View MoreLIAONING DMSO CHEMICALS CO.,LTD.
website:http://www.chinadmso.com
Contact:+86-427-6503033
Address:FLOOR 16, BLOCK A, FINANCIAL SQUARE, XINGLONGTAI DISTRICT, PANJIN CITY, LIAONING P.R. CHINA
shandong zhongke taidou chemical co.,ltd
Contact:86-531-88682301
Address:Jinan shandong Province CHina
Shanghai Synmedia Chemical Co., Ltd
Contact:+86-21-38681880
Address:6th Floor, 11A Building, No.528 Ruiqing Road, Heqing town, Pudong new district, Shanghai China
Contact:086-027-83820093
Address:16#luojiashan, wuchang district
Tianjin Pharmacn Medical Technology Co.,Ltd.
Contact:86-22-60122566ext.866(English),23359620
Address:Green Industrial Base, 6 Haitaifazhan Sixth Rd., Huayuan Industrial Area, Tianjin, 300384, China
Doi:10.1021/ja01369a055
(1930)Doi:10.1016/S0040-4039(01)81393-9
(1984)Doi:10.1055/s-1981-29368
(1981)Doi:10.1002/anie.200460791
(2004)Doi:10.1016/j.tetlet.2004.08.021
(2004)Doi:10.1007/BF00955267
()